Similarly, Galleggiante et al.54 characterized RCC cells that stained positive for CD133, CD24, and copper transport protein 2, a membrane marker important in RCC cisplatin-based resistance and that lacked mesenchymal markers. The gene discussed is CD24; the disease is renal cell carcinoma.